Printer Friendly

Divine Skin Inc to commence manufacturing new OTC analgesic pain reliever drug.

M2 EQUITYBITES-June 27, 2012-Divine Skin Inc to commence manufacturing new OTC analgesic pain reliever drug(C)2012 M2 COMMUNICATIONS http://www.m2.com

Pharmaceutical therapies company Divine Skin Inc (OTC BB:DSKX) reported on Tuesday the receipt of a Drug Enforcement Agency license to produce and distribute Ephedrine containing drugs and other controlled substances in partnership with its manufacturing partner.

Currently, the company is working on a new OTC analgesic, which it believes could provide an alternative to current OTC pain relievers.

This mandatory license is reportedly the final step in commencing manufacturing of its OTC pain reliever.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2012 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jun 27, 2012
Words:109
Previous Article:-Washington approves Ex-Im Bank loan to Vietnam.
Next Article:Telia to further develop 4G network in Denmark.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters